Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 433.22
+3.11 (0.72%)
At close: Aug 13, 2025
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 41.78 billion as of August 14, 2025. Its market cap has increased by 79.68% in one year.
Market Cap
41.78B
Enterprise Value
41.69B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
433.22
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 41.78B, an increase of 65,981.12%. That is a compound annual growth rate of 35.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.13B |
| GSK plc | 56.32B |
| Haleon | 31.67B |
| Smith & Nephew | 11.73B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.01B |
| HUTCHMED (China) | 1.93B |